Rifaximin

Chemical formula: C₄₃H₅₁N₃O₁₁  Molecular mass: 785.879 g/mol  PubChem compound: 6436173

Therapeutic indications

Rifaximin is indicated for:

Travellers' diarrhoea

Population group: only adults (18 years old or older)

Rifaximin is indicated for the treatment of travellers' diarrhoea that is not associated with any of:

  • Fever.
  • Bloody diarrhoea.
  • Eight or more unformed stools in the previous 24h.
  • Occult blood or leucocytes in the stool.

Rifaximin may shorten the duration of diarrhoea when this is associated with non-invasive strains of E.coli.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastrointestinal infections

Population group: only adults (18 years old or older)

Infection of gastrointestinal tract and additionally Rifaximin susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hepatic encephalopathy

Population group: only adults (18 years old or older)

Rifaximin is indicated for the reduction in recurrence of episodes of overt hepatic encephalopathy in patients ≥18 years of age.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Rifaximin is contraindicated in the following cases:

Intestinal obstruction

Intestinal obstruction

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.